Northwest Biotherapeutics (NWBO) Operating Margin (QoQ) (2013 - 2026)
Northwest Biotherapeutics (NWBO) Operating Margin (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn |
| 10 | Northwest Biotherapeutics | 275.76 Mn | 273.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,695.00 |
| Dec 31, 2025 | 515,048.00 |
| Sep 30, 2025 | 412,168.00 |
| Jun 30, 2025 | -666,541.00 |
| Mar 31, 2025 | 339,196.00 |
| Dec 31, 2024 | -386,229.00 |
| Sep 30, 2024 | -72,162.00 |
| Jun 30, 2024 | 211,935.00 |
| Mar 31, 2024 | -214,097.00 |
| Dec 31, 2023 | 248.00 |
| Sep 30, 2023 | 334,955.00 |
| Jun 30, 2023 | -528,154.00 |
| Mar 31, 2023 | 157,171.00 |
| Dec 31, 2022 | 453,666.00 |
| Sep 30, 2022 | -315,828.00 |
| Jun 30, 2022 | -137,464.00 |
| Sep 30, 2021 | 11,131.00 |
| Jun 30, 2021 | 520,583.00 |
| Mar 31, 2021 | -354,435.00 |
| Dec 31, 2020 | 1.75 Mn |